Related Experiment Video
Updated: Jan 30, 2026

Systematic Assessment of Mammalian Skull Specimens for Dental and Temporomandibular Joint Pathology
Published on: August 22, 2022
Efficacy of prolotherapy in temporomandibular joint disorders with hypertonic dextrose and Polydeoxyribonucleotide
Jin-Won Choi1, Young-Kyun Kim1,2, Pil-Young Yun1,3
1Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang Hospital, 13620 Seongnam-si, Republic of Korea.
Background:
This study evaluated the clinical efficacy of prolotherapy using hypertonic dextrose and polydeoxyribonucleotide (PDRN) in patients with temporomandibular joint disorders (TMDs) who did not respond to conventional treatments.
Methods:
A retrospective chart review of 66 patients diagnosed with TMD was conducted. Patients underwent prolotherapy between March and December 2024 and were classified into soft-tissue-related and bone-related TMD groups. Treatment involved injections of hypertonic dextrose or PDRN targeting anatomical structures within the temporomandibular joint (TMJ). Pain and function were assessed using the visual analog scale (VAS) and maximum mouth opening (MMO). Additional parameters, including joint sounds and jaw displacement (S deviation or L deflection), were analyzed. Outcomes were measured at baseline, after each prolotherapy session, and during the final follow-up. Statistical analyses included paired t-tests, McNemar's tests, Analysis of Variance (ANOVA), and regression modeling.
Results:
Prolotherapy was administered an average of 2.3 times per patient. The baseline VAS score decreased from 4.34 ± 2.12 to 1.00 ± 1.58 (p < 0.001), and MMO improved from 31.0 ± 8.7 mm to 40.8 ± 4.55 mm (p < 0.001). Joint sounds, jaw displacement, and deflection also showed significant reductions. Comparative analysis of prolotherapy agents revealed no statistically significant differences between the PDRN and dextrose groups, although both demonstrated significant improvements in MMO and VAS scores. Among patients with baseline joint sounds, 23 individuals experienced complete resolution of sounds, along with significant reductions in jaw displacement (69.6% to 13.0%, p < 0.001) and deflection (52.2% to 8.7%, p < 0.001).
Conclusions:
Prolotherapy is an effective intervention for improving pain and jaw function in TMD patients. Both hypertonic dextrose and PDRN demonstrated significant clinical improvements on TMD prolotherapy.
Related Concept Videos
Structural Joints: Synovial Joints
Structural Joints: Fibrous Joints
Suture
All the bones of the skull, except for the mandible, are joined to each other by a fibrous joint called a suture. The fibrous connective tissue found at a suture strongly unites the adjacent skull bones and thus helps to protect the brain and form the face. In...
Structural Joints: Cartilaginous Joints
There are two types of cartilaginous joints:
Synchondrosis
A synchondrosis ("joined by cartilage") is a cartilaginous joint where bones are connected by hyaline cartilage. Synchondrosis may be temporary...
Joints
Structural joint classifications are based on the material that makes up the joint as well as whether or not the joint contains a space between the bones. Joints are structurally classified as fibrous, cartilaginous, or synovial.
Fibrous Joints Are Immovable
The bones of a...
Self-Efficacy
Method of Joints
Since plane truss members are in the same plane, each joint is subjected to a coplanar and concurrent force system. To apply the method of joints, the first step is to...

